Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Clinical utility pharmacogenomics

Holtzmann NA. Clinical utility of pharmacogenetics and pharmacogenomics. In Rothstein MA, ed. Pharmacogenomics. Social, ethical, and clinical dimensions. HobokenNew Jersey John Wiley Sons, Hoboken, New Jersey. [Pg.264]

Andersson T, Flockhart DA, Goldstein DB, et al. Drug-metabolizing enzymes evidence for clinical utility of pharmacogenomic tests. Clin Pharmacol Ther 2005 78(6) 559—81. [Pg.28]

New genomic and proteomic technologies provide powerful tools for the selection of patients likely to benefit from a therapeutic program without unacceptable adverse events. In this chapter we attempt to clarify how pharmacogenomic biomarker classifiers of the patients most likely to benefit from a drug can be identified and utilized during clinical development. [Pg.328]

Innocenti F, Ratain MJ. Pharmacogenetics of irinotecan clinical perspectives on the utility of genotyping. Pharmacogenomics 2006 7(8) 1211-1221. [Pg.115]

See other pages where Clinical utility pharmacogenomics is mentioned: [Pg.249]    [Pg.249]    [Pg.5]    [Pg.112]    [Pg.129]    [Pg.165]    [Pg.175]    [Pg.276]    [Pg.282]    [Pg.320]    [Pg.221]    [Pg.334]    [Pg.126]    [Pg.38]    [Pg.38]    [Pg.228]    [Pg.228]    [Pg.8]    [Pg.156]    [Pg.276]    [Pg.23]    [Pg.139]    [Pg.381]    [Pg.381]    [Pg.31]    [Pg.42]    [Pg.247]    [Pg.305]    [Pg.173]    [Pg.524]    [Pg.679]    [Pg.679]    [Pg.695]    [Pg.203]    [Pg.217]    [Pg.418]   


SEARCH



Pharmacogenomic

Pharmacogenomics

© 2024 chempedia.info